Attention PC - This how it's going to be

[Anonymous]

Sadly bottom line PC is going to need a lot less people to sell Lyrica and Eliquis (remember its only a copromote we dont own it) which are the only ones with decent revenue moving forward unless we buy something or get the Jac which we should since we call on Rheums already (Ill bet those jobs are frozen). Take your chances and hope you survive the cut or look for a new job while you still have one (which is easier) - pick your poison.

 

[Anonymous]

Sadly bottom line PC is going to need a lot less people to sell Lyrica and Eliquis (remember its only a copromote we dont own it) which are the only ones with decent revenue moving forward unless we buy something or get the Jac which we should since we call on Rheums already (Ill bet those jobs are frozen). Take your chances and hope you survive the cut or look for a new job while you still have one (which is easier) - pick your poison.

Don't forget, we keep losing revenue. Lipitor (obviously), Pristiq to psychs (30% of sales) and now part of Premarin Oral and Chantix (depending on what part of the country). PC will def. get smaller. How many people do you need selling our products. Do you realize many offices have two PC reps selling the same products (and likely a DM) in their office every week? Not including the A or B side reps doing the same thing.

Embarassing to say the least.

 

[Anonymous]

Whatever! HQ is still making money. Shit, they don't even pay us anymore for Chantix, Premarin Oral and Detrol LA. Those are just the ones we have in our portfolio. Don't forget the "other portfolio" that PDI promotes. In regards to Eliquis, everyone in my district has only one BMS counterpart and it sounds like we split responsibility on hospital coverage and pc customers (share cards). In regards to Jak, it should go to the B side. Why dedicate an entire sales force to one drug? Stupidity! Think its a HQ turf war with PC and Specialty pure and simple. Hopefully this new guys puts the kabash on that shitty decision.

 

[Anonymous]

Sadly bottom line PC is going to need a lot less people to sell Lyrica and Eliquis (remember its only a copromote we dont own it) which are the only ones with decent revenue moving forward unless we buy something or get the Jac which we should since we call on Rheums already (Ill bet those jobs are frozen). Take your chances and hope you survive the cut or look for a new job while you still have one (which is easier) - pick your poison.

Actually, we own 50%. Not a co-promote, but a joint venture. Douche.

 

[Anonymous]

I heard B side is probably getting Zyvox for the start of the 4th QTR, if true, it is good news for us. Anything new to sell is good.